Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix

被引:22
作者
Maruo, T [1 ]
Yoshida, S [1 ]
Samoto, T [1 ]
Tateiwa, Y [1 ]
Peng, XJ [1 ]
Takeuchi, S [1 ]
Motoyama, S [1 ]
机构
[1] Kobe Univ, Sch Med, Dept Obstet & Gynecol, Chuo Ku, Kobe, Hyogo 650, Japan
关键词
SCC antigen; epidermal growth factor; epidermal growth factor receptor; estrogen; thyroid hormone;
D O I
10.1159/000030043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Expression of squamous cell carcinoma (SCC) antigen emerged concurrently with squamous formation of the uterine cervix and increased during the neoplastic transformation of the cervical squamous epithelium. SCC antigen expression differed considerably among the histomorphologic cell types of cervical carcinoma. Large cell nonkeratinizing carcinoma contained high levels of the antigen. In contrast, no appreciable expression of SCC antigen was observed in small cell nonkeratinizing carcinoma. The pattern of SCC antigen expression closely coincided with EGF receptor (EGF-R) expression in cervical squamous neoplasia. This suggests that the expression of SCC and EGF-R in cervical carcinoma is related to the differentiation or dedifferentiation processes of the tumor cells. SCC production by CaSki cervical epidermoid carcinoma cells was stimulated by EGF. IL seems likely that an autocrine system, in which EGF serves as the signal, may exist in cervical squamous carcinoma. 17 beta-estradiol and L-triiodothyronine were found to upregulate EGF-R expression, proliferative potential and SCC production in the CaSki cervical carcinoma cells.
引用
收藏
页码:494 / 504
页数:11
相关论文
共 20 条
[1]  
DEPALO L, 1988, CANCER RES, V48, P1105
[2]  
Hoshina M, 1986, Asia Oceania J Obstet Gynaecol, V12, P119
[3]   PRODUCTION OF TUMOR-ASSOCIATED ANTIGEN, TA-4, BY THE CASKI CERVICAL-CARCINOMA CELL-LINE [J].
HUSSA, RO ;
MARUO, T ;
STROBEL, JL ;
PATTILLO, RA ;
MOCHIZUKI, M .
OBSTETRICS AND GYNECOLOGY, 1986, 67 (06) :802-805
[4]   PROGNOSTIC-SIGNIFICANCE OF THE TUMOR-ANTIGEN TA-4 IN SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX [J].
KATO, H ;
MORIOKA, H ;
ARAMAKI, S ;
TAMAI, K ;
TORIGOE, T .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 145 (03) :350-354
[5]  
KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO
[6]  
2-I
[7]   CARCINOEMBRYONIC ANTIGEN IN CANCER OF FEMALE REPRODUCTIVE SYSTEM - SEQUENTIAL LEVELS AND EFFECTS OF TREATMENT [J].
KHOO, SK ;
MACKAY, EV .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1973, 13 (01) :1-7
[8]  
KIMURA A, 1987, Journal of Japan Society for Cancer Therapy, V22, P1159
[9]  
Kobayashi M, 1989, Nihon Sanka Fujinka Gakkai Zasshi, V41, P412
[10]  
MARUO T, 1992, CANCER, V69, P1182